Liphetolelo tse amohelehang tsa theko e tlaase ea Synthroid le Levoxyl
Ka la 23 June, 2004, US Food and Drug Administration (FDA) e ile ea hana Citation Petit - Abbott - maker of Synthroid - ka August 2003 mabapi le bioquivalence ea levothyroxine lihlahisoa tsa sodium. Khampani e ile ea re mekhoa ea ho khetholla li-bioequivalence e ne e na le phoso, 'me e ka bolela hore lihlahisoa tsa mekhoa e fapaneng e ka nkoa e le bioequivalent.
Leha ho le joalo, FDA, e ile ea hana kōpo ena, e ileng ea bula lemati bakeng sa lihlahisoa tsa generic levothyroxine.
Baetsi ba bangata ba ne ba eme ka mapheo e le lik'hamphani tse tharo tse fapaneng tse phatlalalitsoeng ka la 24 June, 2004, hore li amohetse tumello ea FDA bakeng sa lihlahisoa tsa bona tsa levothyroxine, tse akarelletsang:
Mylan Laboratories - e ileng ea amohela tumello ea matlapa a sodium levothyroxine ka mefuta e sa tšoaneng ea matla, li-synthroid tse tloaelehileng.
Sandoz Inc. - Lebelo la AB-rated (bioquivalent) levothyroxine ho Synthroid le Levoxyl.
Lannett Company - tumello ea levothyroxine e entsoeng ke Jerome Stevens Pharmaceutical, Inc. (JSP), mofani oa khethehileng oa Lannett, e leng bioequivalent le Levoxyl. Tlhokomeliso: Sehlahisoa se entsoeng ke Jerome Stevens 'me se abuoa ke Lannett, se boetse se rekisoa tlas'a lebitso la "Unithroid," e bile levothyroxine ea pele e amoheloang ke FDA.
Joalokaha ho ka lebelloa, baetsi ba li-levothyroxine tse peli tse ka sehloohong ka nako eo, Abbott le Morena, ba ile ba leka ho sireletsa lihlahisoa tsa bona Synthroid le Levoxyl khahlanong le tlhōlisano ena e ncha ea tlhōlisano ea theko e tlase.
Ha lik'hamphani tsena tse tharo li qala ho romella lithethefatsi tsa bona tsa levothyroxine ka potlako, bobeli ba Abbott le Morena ba ile ba bona marotholi a theko ea theko ka tebello ea kabelo ea maruo e lahlehileng
E FETILENG FETA LINKI EA E-MAIL
Ntlha ea pele, lebotho la Abbott la li-PR le lithethefatsi li ne li sa sebetse, ho hlohlelletsa baqolotsi ba litaba le lisebelisoa tsa thepa le bo-rakhoebo le lingaka hore ba tsoele pele ho leka ho beha Synthroid, meriana ea bobeli-e behiloeng ka ho fetisisa United States, 'me mohloli oa $ 818 limilione ka thekiso ka 2003, e le levothyroxine e "molemo".
Le hoja ho ne ho se na lipatlisiso tsa ho theha sena, 'me FDA e phatlalalitse lithethefatsi tsena tsa bioequivalent, ho ne ho e-na le litebelisoa tse matla tsa ho rekisa, li-docs le li-pharmacy ho Synthroid eohle le ho senya lihlahisoa tsa tlhaho. Molaetsa ona o ne o boetse o buuoa ke lingaka, tse ileng tsa bolella bakuli hore "li-generic tse ncha ha lia tšoana le Synthroid."
Ntlha ea bobeli, lik'hamphani tsa lithethefatsi li emisitse lipolelo tsa hore mofuta o mong o molemo ho feta o mong kapa hore lihlahisoa li molemo ho feta li-generics. Ho fihlela joale, lipatlisiso tsa lithaka, tse peli tse foufetseng ha li e-s'o hatisoe tse bapisang katleho le / kapa boleng ba maralo a khethehileng khahlanong le lihlahisoa tsa tlhaho, mme ha ho na bopaki ba hore mofuta o mong oa levothyroxine o molemo ho feta o mong, kapa hore li-generic ha li sebetse ka tsela e lekanang hammoho le lithethefatsi tsa lebitso la levothyroxine.
Ntlha ea boraro, lik'hamphani tsa inshorense le li-HMO li fetisitse bakuli ba bangata ho ea ho levothyroxine e theko e tlaase. Ho na le batho ba bangata ka lithethefatsi tsena tseo esita le lichelete tse seng kae tsa chelete ka khoeli, ha li atolosoa ke bakuli ba likete tse ngata, li felletse ka chelete e ngata ea chelete eo lihlopha tsena li tla li thabela.